Dr Grieb on the Importance of Targeting the MYC Oncogene in CRC and Solid Tumors

Brian C. Grieb, MD, PhD, emphasizes the importance of investigating agents that target the MYC oncogene, as well as supportive cofactors, in colorectal cancer and other tumor types.

Related Keywords

Brianc Grieb , ,Vanderbilt University Medical Center ,Department Of Medicine ,Division Of Hematology Oncology ,D ,Phd ,Targeting The Myc Oncogene ,Patients With Colorectal Cancer ,Target Myc In Crc ,Omomyc ,Mycure Trial ,Nct04808362 ,